Chen Guang Yan
Président chez Chengdu Hepatunn Pharmaceutical Co. Ltd.
Profil
Mr. Chen Guang Yan is Deputy General Manager at Shenzhen Hepalink Pharmaceutical Co., Ltd.
and Chairman at Chengdu Haitong Pharmaceutical Co. Ltd.
He received his undergraduate degree from Peking University.
Postes actifs de Chen Guang Yan
Sociétés | Poste | Début |
---|---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Président | - |
Anciens postes connus de Chen Guang Yan
Sociétés | Poste | Fin |
---|---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Corporate Officer/Principal | 16/05/2014 |
Formation de Chen Guang Yan
Peking University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |